Advertisement

Ads Placeholder
Loading...

Jazz Pharmaceuticals plc

JAZZ•NASDAQ
Healthcare
Biotechnology
$186.95
$-1.32(-0.70%)
U.S. Market opens in 27h 56m

Jazz Pharmaceuticals plc (JAZZ) Stock Overview

Explore Jazz Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.5B
P/E Ratio-32.01
EPS (TTM)$-5.84
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$168.57
3 Months$169.46
1 Year Target$152.31

JAZZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jazz Pharmaceuticals plc (JAZZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $152.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -32.01 and a market capitalization of 11.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.70%
5-Day Change
-1.22%
1-Month Change
0.15%
3-Month Change
7.97%
6-Month Change
34.03%
Year-to-Date (YTD) Change
7.97%
1-Year Change
54.73%
3-Year Change
28.57%
5-Year Change
13.50%
All-Time (Max) Change
954.43%

Contact Information

https://www.jazzpharma.com
353 1 634 7800
Waterloo Exchange, Dublin, NaN, 4

Company Facts

28,000 Employees
IPO DateJun 1, 2007
CountryIE
Actively Trading

Frequently Asked Questions